Edition:
United Kingdom

People: China Regenerative Medicine International Ltd (8158.HK)

8158.HK on Hong Kong Stock

0.22HKD
24 Jun 2019
Change (% chg)

HK$-0.00 (-0.46%)
Prev Close
HK$0.22
Open
HK$0.22
Day's High
HK$0.22
Day's Low
HK$0.21
Volume
887,500
Avg. Vol
1,365,366
52-wk High
HK$3.60
52-wk Low
HK$0.18

Mui, Chi Hung 

Mr. Mui Chi Hung serves as Chief Financial Officer of the Company. He has over 20 years of experience in financing, auditing and accounting. Prior to joining the Company, Mr. Mui held various senior positions in a few listed groups and international accounting firm, including PricewaterhouseCoopers, Lansen Pharmaceutical Holdings Limited (stock code: 503) (“Lansen”), China Smarter Energy Group Holdings Limited (formerly known as “Rising Development Holdings Limited” (stock code: 1004) (“Rising”)) and Legend Strategy International Holdings Group Company Limited (stock code: 1355). He spent 7 years serving as the Financial Controller, Company Secretary and Executive Director in Rising and 5 years serving as the Chief Financial Officer and Company Secretary in Lansen. Mr. Mui obtained his bachelor’s degree in Management majoring in Accounting from the University of Lethbridge in Canada and his master’s degree in Professional Accounting from the Hong Kong Polytechnic University. Mr. Mui is currently a member of AICPA and HKICPA.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --